Novyra Pharmachem Limited (BOM:519353)
10.14
0.00 (0.00%)
At close: Sep 10, 2026
Novyra Pharmachem Revenue
Novyra Pharmachem had revenue of 17.26M INR in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 18.31M, up 3,713.54% year-over-year. In the fiscal year ending March 31, 2026, Novyra Pharmachem had annual revenue of 1.04M.
Revenue (ttm)
18.31M
Revenue Growth
+3,713.54%
P/S Ratio
3.51
Revenue / Employee
6.10M
Employees
3
Market Cap
64.19M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.04M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 1.50M | - | - |
| Mar 31, 2022 | 1.50M | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Elegant Floriculture & Agrotech (India) | 1.48B |
| Stanbik Agro | 858.95M |
| Dhanwel Hybrid Seeds | 745.87M |
| Omega AG Seeds Punjab | 100.78M |
| Raghuvansh Agrofarms | 76.71M |
| Shree Ganesh Bio-Tech (India) | 50.17M |
| TGIF Agribusiness | 33.18M |
| Genomic Valley Biotech | 2.16M |